Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers

• 1. 含粘膜粘附性聚合物的酶、微生物和抗体的控释制剂 [P] . 中国专利： CN1997352B . 2010.12.01
• 2. 含粘膜粘附性聚合物的酶、微生物和抗体的控释制剂 [P] . 中国专利： CN1997352A . 2007-07-11
• 3. Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers [P] . 美国专利： US2008020036A1 . 2008-01-24

  机译： 具有粘膜粘附性聚合物的酶，微生物和抗体的控释制剂

• 4. CONTROLLED RELEASE FORMULATIONS OF ENZYMES, MICROORGANISMS, AND ANTIBODIES WITH MUCOADHESIVE POLYMERS [P] . 欧洲知识产权局专利： EP1784160A1 . 2007-05-16

  机译： 含粘胶聚合物的酶，微生物和抗体的受控释放配方

• 5. CONTROLLED RELEASE FORMULATIONS OF ENZYMES MICROORGANISMS, AND ANTIBODIES WITH MUCOADHESIVE POLYMERS [P] . IN2006DN07704A . 2007-06-15

  机译： 含粘胶聚合物的酶微生物和抗体的受控释放配方

• 1. Formulation development of nifedipine controlled-release coated tablets [J] . Ananya Ubonratana, Sirachaya Choosakul, Nara Nilnakara, 亚洲药物制剂科学(英文) . 2016,第001期
• 2. Efficacy and safety of controlled-releaser oxycodone/naloxone versus controlled-release oxycodone in Korean patientsr with cancer-related pain: a randomized controlled trial [J] . Kyung-Hee Lee, Min Kyoung Kim, Yong Sang Hong, 癌症（英文版） . 2017,第011期
• 3. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. [J] . Han RY, Fang JY, Sung KC, International Journal of Pharmaceutics . 1999,第2期
• 4. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. [J] . Han RY, Fang JY, Sung KC, International Journal of Pharmaceutics . 1999,第2期
• 5. PREPARE AND EVALUATE MUCOADHESIVE FORMULATIONS OF LAMIVUDINE WITH BETTER CONTROLLED/ SUSTAINED DRUG RELEASE PROFILE [J] . Kavita Rathore, C.K. Tyagi, Harish Pandey, Journal of Drug Delivery and Therapeutics . 2019,第4aA期
• 6. Gelatin microspheres with blends of mucoadhesive polymers for controlled release of cimetidine [C] . K.U.Shah, W.J.Irwin, K.J.Lewis, International symposium on controlled release of bioactive materials;Consumer and diversified products conference . 2000
• 7. (1) Development and in vivo testing of a gastric retention device (GRD) in dogs, (2) Product formulations and in vitro-in vivo evaluation of, (a) immediate release formulation of itraconazole, (b) controlled-release formulation of ketoprofen in adults [D] . Kapsi, Shivakumar G. 1999
• 8. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology [O] . Bhupinder Singh, Sukhwinder Kaur Chakkal, Naveen Ahuja 2006
• 9. Formulation and in vitro evaluation of mucoadhesive controlled release matrix tablets of flurbiprofen using response surface methodology [O] . Ikrima Khalid, Mahmood Ahmad, Muhammad Usman Minhas, 2014
• 10. Research and development of controlled release formulations of pesticides. V.1. Development and evaluation of controlled release formulations of pesticides. Proceedings of a seminar held in Vienna, 6-9 September 1993 [R] . 1994

• 1. A Rapid Technique for Prediction of Nutrient Release from Polymer Coated Controlled Release Fertilizers [J] . Shengsen Wang ,Ashok K. Alva ,Yuncong Li . 土壤科学期刊（英文） . 2011,第2期
• 2. Development of controlled release formulations of thiabendazole [J] . Yasser Z. El-Nahhal . 农业化学和环境（英文） . 2014,第1期
• 3. Controlling Drug Release from Titania Nanotube Arrays Using Polymer Nanocarriers and Biopolymer Coating [J] . Moom Sinn Aw ,Karan Gulati ,Dusan Losic . 生物材料与纳米技术（英文） . 2011,第5期
• 4. 可诱导产生具有ACE可逆酶活性抗体酶的半抗原肽的合成 [C] . 许家喜 . 中国化学会第一届有机化学学术会议暨第七届有机合成学术会议,第八届物理有机学术会议,第六届天然有机学术会议 . 1997
• 5. 具有粘附性的阳离子抗菌聚合物的制备及其作用机制研究 [A] . 王亚南 . 2014